Peering Into Vertex Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Vertex Pharmaceuticals' (NYSE:VRTX) short percent of float has fallen 7.55% since its last report, with 2.51 million shares sold short, which is 0.98% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. However, it does not necessarily mean that the stock price will rise in the near term. Compared to its peers, Vertex has less short interest, with an average of 3.55% for its peer group.
August 04, 2023 | 9:40 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Decrease in short interest in Vertex Pharmaceuticals could indicate a more bullish sentiment among traders. However, this does not guarantee a rise in the stock price.
Short interest is the number of shares sold short but not yet covered. A decrease in short interest can signal a more bullish sentiment towards a stock. However, this does not necessarily mean that the stock price will rise in the near term. It's also worth noting that compared to its peers, Vertex has less short interest, which could be interpreted as a positive sign by some investors.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100